Vertex Pharmaceuticals Inc / Ma

LOS ANGELES CAPITAL MANAGEMENT LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

293,301

Value ($000)

123,154

Weight

0.4%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	123,154	0.4%	293,301	12/31/2025
2025 Q3	10/20/2025	13,892	0.0%	35,472	9/30/2025
2025 Q2	8/7/2025	14,698	0.1%	33,014	6/30/2025
2025 Q1	5/5/2025	12,471	0.1%	25,723	3/31/2025
2024 Q4	2/4/2025	524	0.0%	1,302	12/31/2024
2024 Q3	11/4/2024	8,710	0.0%	18,727	9/30/2024
2024 Q2	8/5/2024	30,324	0.1%	64,696	6/30/2024
2024 Q1	4/5/2024	55,476	0.2%	132,714	3/31/2024
2023 Q4	2/6/2024	158,636	0.6%	389,874	12/31/2023
2023 Q3	11/6/2023	148,509	0.6%	427,070	9/30/2023
2023 Q2	8/3/2023	149,994	0.6%	426,228	6/30/2023
2023 Q1	5/4/2023	144,036	0.6%	457,155	3/31/2023
2022 Q4	2/6/2023	129,088	0.6%	447,011	12/31/2022
2022 Q3	11/2/2022	125,813	0.7%	434,526	9/30/2022
2022 Q2	8/5/2022	95,095	0.5%	337,466	6/30/2022
2022 Q1	5/6/2022	92,597	0.4%	354,818	3/31/2022
2021 Q4	2/3/2022	66,320	0.2%	302,005	12/31/2021
2021 Q3	11/8/2021	27,957	0.1%	154,129	9/30/2021
2021 Q2	8/5/2021	34,147	0.2%	169,357	6/30/2021
2021 Q1	5/5/2021	48,226	0.2%	224,420	3/31/2021
2020 Q4	3/10/2021	72,572	0.3%	307,064	12/31/2020
2020 Q3	11/2/2020	86,076	0.4%	316,315	9/30/2020
2020 Q2	8/5/2020	96,648	0.5%	332,912	6/30/2020
2020 Q1	5/4/2020	73,883	0.5%	310,500	3/31/2020
2019 Q4	2/7/2020	67,023	0.3%	306,110	12/31/2019
2014 Q1	5/12/2014	5,852	0.1%	82,744	3/31/2014
2013 Q4	2/4/2014	8,459	0.1%	113,854	12/31/2013